Cargando…
Understanding Glioblastoma Biomarkers: Knocking a Mountain with a Hammer
Gliomas are the most frequent and deadly form of human primary brain tumors. Among them, the most common and aggressive type is the high-grade glioblastoma multiforme (GBM), which rapidly grows and renders patients a very poor prognosis. Meanwhile, cancer stem cells (CSCs) have been determined in gl...
Autores principales: | Hassn Mesrati, Malak, Behrooz, Amir Barzegar, Y. Abuhamad, Asmaa, Syahir, Amir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291262/ https://www.ncbi.nlm.nih.gov/pubmed/32429463 http://dx.doi.org/10.3390/cells9051236 |
Ejemplares similares
-
CD44: A Multifunctional Mediator of Cancer Progression
por: Hassn Mesrati, Malak, et al.
Publicado: (2021) -
Nanotechnology-Based Combinatorial Anti-Glioblastoma Therapies: Moving from Terminal to Treatable
por: Barzegar Behrooz, Amir, et al.
Publicado: (2022) -
Could We Address the Interplay Between CD133, Wnt/β-Catenin, and TERT Signaling Pathways as a Potential Target for Glioblastoma Therapy?
por: Behrooz, Amir Barzegar, et al.
Publicado: (2021) -
Immunology Meets Bioengineering: Improving the Effectiveness of Glioblastoma Immunotherapy
por: Fekrirad, Zahra, et al.
Publicado: (2022) -
Wnt and PI3K/Akt/mTOR Survival Pathways as Therapeutic Targets in Glioblastoma
por: Barzegar Behrooz, Amir, et al.
Publicado: (2022)